Search

everythinglearnresearchcommunity

for

Search:↓

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Early treatment of EPDS can improve outcomes and reduce recurrence risk.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.

Skin diseases differ between Ghana and the UK, with infections most common in Ghana and malignant skin diseases most prevalent in the UK.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Genetic testing confirmed a rare skin disorder in a young girl, which improved with zinc supplementation.

Thyroid function affects skin health, with a complex interaction between the two.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

An 11-year-old female Pinscher with Pemphigus Foliaceus was successfully diagnosed and treated.

Skin treatment can lower life quality for patients with skin conditions.

People with certain skin conditions, especially androgenic alopecia, are more likely to have metabolic syndrome.

Fat-derived stem cells show promise for treating skin issues and improving wound healing, but more research is needed to confirm the best way to use them.

A gene deletion in mice causes weak protein, immune issues, hair loss, airway problems, and wasting disease.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Scalp involvement in pemphigus means the disease is more severe and harder to treat.

Testing hair roots with a special dye is a simple, non-invasive way to check disease progress in pemphigus vulgaris patients.

Topical treatments led to hair regrowth in a man with linear morphea.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

EPDS is a rare, chronic scalp condition that's hard to treat and needs better awareness for improved outcomes.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.